Susceptibility Genes for Age-Related Maculopathy on Chromosome 10q26
Open accessThe DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
On the basis of genomewide linkage studies of families affected with age-related maculopathy (ARM), we previously identified a significant linkage peak on 10q26, which has been independently replicated by several groups. We performed a focused SNP genotyping study of our families and an additional control cohort. We identified a strong association signal overlying three genes, PLEKHA1, LOC387715, and PRSS11. All nonsynonymous SNPs in this critical region were genotyped, yielding a highly significant association (P < .00001) between PLEKHA1/LOC387715 and ARM. Although it is difficult to determine statistically which of these two genes is most important, SNPs in PLEKHA1 are more likely to account for the linkage signal in this region than are SNPs in LOC387715; thus, this gene and its alleles are implicated as an important risk factor for ARM. We also found weaker evidence supporting the possible involvement of the GRK5/RGS10 locus in ARM. These associations appear to be independent of the association of ARM with the Y402H allele of complement factor H, which has previously been reported as a major susceptibility factor for ARM. The combination of our analyses strongly implicates PLEKHA1/LOC387715 as primarily responsible for the evidence of linkage of ARM to the 10q26 locus and as a major contributor to ARM susceptibility. The association of either a single or a double copy of the high-risk allele within the PLEKHA1/LOC387715 locus accounts for an odds ratio of 5.0 (95% confidence interval 3.2-7.9) for ARM and a population attributable risk as high as 57%.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many linkage and association studies have indicated that the most replicated signals reside on chromosome 1q25–31 and 10q26 (Fisher et al., 2005; Jakobsdottir et al., 2005; Klein et al., 1998; Majewski et al., 2003).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Jakobsdottir et al., 2005
In the citing paper
“Our data, including a population-based study (Wang et al., 2008), and data by Jakobsdottir and colleagues (Jakobsdottir et al., 2005) have both shown that the frequency of the ARMS2 risk allele is higher in patients with advanced AMD than in those with early or intermediate AMD.”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Jakobsdottir et al., 2005
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [13]
In the citing paper
“The association signal in this region was initially identified as a result of fine-mapping efforts designed to narrow the chromosome 10q26 linkage peak (80, 122).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [80]
In the citing paper
“A second important locus LOC387715(ARMS2)/HtrA1 (high temperature requirement factor A-1), located on chromosome 10q26, has also been found to be associated with advanced age-related macular degeneration.60,68–71”
From Age-related macular degeneration (2008) · cites this paper as [68]
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525 · cited 3×
“We chose to cluster the SNPs so that each SNP had a correlation coefficient (r2) 10.5 with at least one htSNP; we used HaploView (Barrett et al. 2005) to get a graphical view of SNP-SNP LD along both chromosomes, and we compared LD estimates of htSNPs with SNPs omitted by H-clust.”
MethodInfluentialComplement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Merlin—rapid analysis of dense genetic maps using sparse gene flow trees
Abecasis, G. R., Cherny, S. S., Cookson, W. O., & Cardon, L. R. (2002) · Nature Genetics · doi:10.1038/ng786 · Cited by 3,354
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449 · cited 4×
“These results strongly support earlier findings of CFH’s involvement in ARM (Conley et al. 2005; Edwards et al. 2005; Hageman et al. 2005; Haines et al. 2005; Klein et al. 2005; Zareparsi et al. 2005a).”
BackgroundResultInfluentialComplement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424 · cited 4×
“These results strongly support earlier findings of CFH’s involvement in ARM (Conley et al. 2005; Edwards et al. 2005; Hageman et al. 2005; Haines et al. 2005; Klein et al. 2005; Zareparsi et al. 2005a).”
BackgroundResultInfluentialPedCheck: A Program for Identification of Genotype Incompatibilities in Linkage Analysis
O'Connell, J. R., & Weeks, D. E. (1998) · The American Journal of Human Genetics · doi:10.1086/301904 · Cited by 2,056
Self-citationHageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961 · cited 2×
“These results strongly support earlier findings of CFH’s involvement in ARM (Conley et al. 2005; Edwards et al. 2005; Hageman et al. 2005; Haines et al. 2005; Klein et al. 2005; Zareparsi et al. 2005a).”
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265 · cited 1×
“…of playing a role in ARM, as a result of the work of Hageman and Anderson (Hageman and Mullins 1999; Johnson et al. 2000, 2001; Mullins et al. 2000; Hageman et al. 2001), who have shown that the subretinal deposits (drusen) that are observed in many patients with ARM contain complement factors.”
BackgroundMullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937 · cited 2×
“…been suspected of playing a role in ARM, as a result of the work of Hageman and Anderson (Hageman and Mullins 1999; Johnson et al. 2000, 2001; Mullins et al. 2000; Hageman et al. 2001), who have shown that the subretinal deposits (drusen) that are observed in many patients with ARM contain…”
BackgroundResult
Research works printed but not linked: 1
- Lange, 2001, MENDEL version 4.0: a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets, Am J Hum Genet Suppl, 69, A1886
Cited by
Items 301–400 of 471
Ulańczyk, Z., Grabowicz, A., Mozolewska‐Piotrowska, K., Safranow, K., Kawa, M. P., Pałucha, A., Krawczyk, M., Sikora, P., Matczyńska, E., Machaliński, B., et al. (2020) · Acta Ophthalmologica · doi:10.1111/aos.14721 · Cited by 16
The interplay of oxidative stress and ARMS2-HTRA1 genetic risk in neovascular AMD
Lu, Z., May, A., Dinh, B., Lin, V., Su, F., Tran, C., Adivikolanu, H., Ehlen, R., Che, B., Wang, Z., et al. (2021) · Vessel Plus · doi:10.20517/2574-1209.2020.48 · Cited by 18
“However, ARMS2 seems to be an unlikely source for AMD pathogenicity due to (1) its weak expression in the retina([131,132,136,137]) and (2) a recent expression Figure 3.”
BackgroundChang, Y.-J., Jenny, L. A., Li, Y.-S., Cui, X., Kong, Y., Li, Y., Sparrow, J. R., & Tsang, S. H. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2215005120 · Cited by 17
Feehan, M., Hartman, J. M., Durante, R., Morrison, M. A., Miller, J. W., Kim, I. K., & DeAngelis, M. M. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-83 · Cited by 16
“Additionally, other strongly associated variants with large influence on AMD risk, particularly the neovascular subtype, are found in the ARMS2/ HTRA1 genes on chromosome 10q26[44-49].”
BackgroundQuellec, G., Russell, S. R., Scheetz, T. E., Stone, E. M., & Abràmoff, M. D. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6232 · Cited by 15
Lee, A., & Brantley, M. A. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.10.1547 · Cited by 17
The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype
Loane, E., Nolan, J. M., McKay, G. J., & Beatty, S. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.07.005 · Cited by 16
“In 2005, CFH and ARMS2 were identified as the major risk genes for AMD, which together have been estimated to account for over 50% of risk for developing this disease (Edwards et al., 2005; Gotoh et al., 2009; Hageman et al., 2005; Haines et al., 2005; Jakobsdottir et al., 2005; Rivera et al., 2005; Seddon et al., 200…”
BackgroundWhole exome sequencing of extreme age-related macular degeneration phenotypes.
Sardell, R. J., Bailey, J. N. C., Courtenay, M. D., Whitehead, P. L., Laux, R. A., Adams, L. D., Fortun, J. A., Brantley, M. A., Kovach, J. L., Schwartz, S. G., et al. (2016) · PubMed Central · Cited by 17
AMD Genetics: Methods and Analyses for Association, Progression, and Prediction
Yan, Q., Ding, Y., Weeks, D. E., & Chen, W. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-66014-7_7 · Cited by 14
Self-citationA novel ARMS2 splice variant is identified in human retina
Wang, G., Scott, W. K., Whitehead, P. G., Court, B. L., Kovach, J. L., Schwartz, S. G., Agarwal, A., Dubovy, S. R., Haines, J. L., & Pericak‐Vance, M. A. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.11.005 · Cited by 16
“Studies have shown that the AMDassociated haplotype includes thesingle nucleotide polymorphisms (SNPs) rs10490924 in gene ARMS2 (Age-related maculopathy susceptibility 2, previously known as hypothetical LOC387715) and rs11200638 in the promoter region of HTRA1 (High-temperature requirement protein A1) (Jakobsdottir e…”
Backgroundde Almeida, L. N. F., Melilo-Carolino, R., Veloso, C. E. D. R., Pereira, P. A., Bastos‐Rodrigues, L., Sarubi, H., de Miranda, D. M., Soubrane, G., Marco, L. A. D., & Nehemy, M. B. (2013) · Ophthalmic Research · doi:10.1159/000350549 · Cited by 15
Complement Deposits on Ocular Tissues Adjacent to Sites of Inflammation
Montalvo, V., Chan, C., Gery, I., Campos, M. M., Wawrousek, E. F., Bush, R. A., & Lambris, J. D. (2007) · Current Eye Research · doi:10.1080/02713680701656343 · Cited by 14
Carboxyethylpyrrole Adducts, Age-related Macular Degeneration and Neovascularization
Renganathan, K., Ebrahem, Q., Vasanji, A., Gu, X., Lu, L., Sears, J. E., Salomon, R. G., Anand‐Apte, B., & Crabb, J. W. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-74904-4_30 · Cited by 14
No association between the T280M polymorphism of the CX3CR1 gene and exudative AMD
Zerbib, J., Puche, N., Richard, F., Leveziel, N., Cohen, S. Y., Korobelnik, J., Sahel, J., Münnich, A., Kaplan, J., Rozet, J., et al. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.05.005 · Cited by 18
Kanoff, J. M., & Miller, J. W. (2013) · Seminars in Ophthalmology · doi:10.3109/08820538.2013.825292 · Cited by 15
“A second major chromosomal region contributing to the genetic risk of macular degeneration is the 10q26 locus.(17) A significant number of AMD patients may have mutations in this chromosomal region since the attributable risk is up to 57%.”
BackgroundPei, X., Ma, K., Xu, J., Wang, N., & Liu, N. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2901-2 · Cited by 13
“Age-related macular degeneration (AMD) is a leading cause of irreversible blindness in the elderly [1–3].”
BackgroundInfluentialSohn, E. H., Han, I. C., Roos, B. R., Faga, B., Luse, M. A., Binkley, E. M., Boldt, H. C., Folk, J. C., Russell, S. R., Mullins, R. F., et al. (2021) · Ophthalmology Science · doi:10.1016/j.xops.2020.100002 · Cited by 16
Genetics of Age-related Macular Degeneration
Edwards, A. O. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-74904-4_24 · Cited by 14
Stem Cells as Tools for Studying the Genetics of Inherited Retinal Degenerations
Wiley, L. A., Burnight, E. R., Mullins, R. F., Stone, E. M., & Tucker, B. A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017160 · Cited by 16
“Genome wide association studies of AMD identified two loci on chromosomes 1 and 10 that are highly associated with disease risk (Edwards et al. 2005; Haines et al. 2005; Jakobsdottir et al. 2005; Klein et al. 2005; Rivera et al. 2005; Zareparsi et al. 2005; Schwartz et al. 2012).”
BackgroundZouache, M. A., Richards, B. T., Pappas, C. M., Anstadt, R. A., Liu, J., Corsetti, T., Matthews, S., Seager, N. A., Schmitz-Valckenberg, S., Fleckenstein, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44605-0 · Cited by 14
“…in regulation of the alternative complement pathway (AP) on chromosome 1q32 (Chr1 AMD locus) and variants associated with two neighboring genes on chromosome 10q26 (Chr10 AMD locus), age-related maculopathy susceptibility 2 ( ARMS2 ) and high-temperature requirement factor A1 ( HTRA1 ) 17,18 .”
Role of Complement in the Onset of Age-Related Macular Degeneration
Piri, N., & Kaplan, H. J. (2023) · Biomolecules · doi:10.3390/biom13050832 · Cited by 15
Genetics of Age-Related Macular Degeneration: Update
Scholl, H. P. N., Fleckenstein, M., Issa, P. C., Keilhauer, C. N., Holz, F. G., & Weber, B. H. F. (2007) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-540-33672-3_3 · Cited by 15
Hall, J. C., Paull, D. J., Pébay, A., & Lidgerwood, G. E. (2022) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14128 · Cited by 12
“Furthermore, variants at the LOC387715/ARMS2/HTRA1 (rs10490924 T/T) locus have been identified as major contributors to AMD development.(68,69) To date, genome-wide association studies (GWAS) have identified over 30 independent loci where a common risk allele is associated with an increased risk of AMD.”
BackgroundBando, H., Shadrach, K. G., Rayborn, M. E., Crabb, J. W., & Hollyfield, J. G. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.09.008 · Cited by 12
Gorin, M. B., Weeks, D. E., Baron, R., Conley, Y. P., Ortube, M. C., & Nusinowitz, S. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041335 · Cited by 11
“Two of the major loci that were reported in several family-based linkage studies, 1q31 and 10q26 were the subject of candidate gene testing of variants in both family-based and case-control cohorts and led to the discovery of the roles of complement factor H (CFH) [2–5] and the ARMS2/HTRA1 genes [6,7] in AMD risk.”
BackgroundSelf-citationKim, Y. H., Kim, H., Mok, J. W., & Joo, C. (2013) · Ophthalmic Genetics · doi:10.3109/13816810.2012.749287 · Cited by 12
Gene Structure of the 10q26 Locus: A Clue to Cracking the ARMS2/HTRA1 Riddle?
Körtvely, E., & Ueffing, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_4 · Cited by 11
Genetic Control of Complement Activation in Humans and Age Related Macular Degeneration
Hecker, L. A., & Edwards, A. O. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_4 · Cited by 13
Spencer, K. L., Olson, L. M., Schnetz‐Boutaud, N. C., Gallins, P. J., Wang, G., Scott, W. K., Agarwal, A., Jakobsdóttir, J., Conley, Y. P., Weeks, D. E., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-5112 · Cited by 12
Self-citationRanibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration
Kaiser, P. K. (2007) · Core evidence · doi:10.2147/ce.s7437 · Cited by 12
Hirata, F. E., de Vasconcellos, J. P. C., Medina, F. M., Rim, P. H. H., Fulco, E. A. M., & de Melo, M. B. (2013) · Ophthalmic Genetics · doi:10.3109/13816810.2013.867449 · Cited by 13
Bonyadi, M. H. J., Yaseri, M., Nikkhah, H., Bonyadi, M., Nazari, R., & Soheilian, M. (2018) · International Ophthalmology · doi:10.1007/s10792-018-0853-y · Cited by 11
Genomic determinants of biological age estimated by deep learning applied to retinal images
Huang, Y., Syed, M. G., Chen, R., Li, C., Shang, X., Wang, W., Zhang, X., Zhang, X., Tang, S., Liu, J., et al. (2025) · GeroScience · doi:10.1007/s11357-024-01481-w · Cited by 13
Photobiomodulation Therapy for Non-exudative Age-related Macular Degeneration
Rodriguez, D. A., Song, A., Bhatnagar, A., & Weng, C. Y. (2024) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000543 · Cited by 10
Baird, P. N., & Chakrabarti, S. (2013) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12235 · Cited by 10
Gupta, D., Gupta, V., Singh, V., Chawla, S., Parveen, F., Agrawal, S., & Phadke, S. R. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.07.005 · Cited by 10
Marioli, D. I., Pharmakakis, N. M., Deli, A., Havvas, I., & Zarkadis, I. K. (2009) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1129-z · Cited by 11
Qian, D.-G., Kan, M., Weng, X., Huang, Y., Zhou, C., Gen-long, Y., Wang, T., Zhou, D., Zhang, Z., Zhang, D., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.37 · Cited by 12
Génétique de la dégénérescence maculaire liée à l’âge
Leveziel, N., Puche, N., Zerbib, J., Benlian, P., COSCAS, G. J., Soubrane, G., & Souied, E. H. (2010) · médecine/sciences · doi:10.1051/medsci/2010265509 · Cited by 12
“Gènes LOC387715/HTRA1/PLEKHA1 Les gènes LOC387715, HTRA1 et PLEKHA1 sont localisés dans une région de 0,1 Mb en 10q26, identifiée dans plusieurs études d’association [19-21].”
Fang, K., Gao, P., Tian, J., Qin, X., Yu, W., Li, J., Chen, Q., Huang, L., Chen, D., Hu, Y., et al. (2015) · Journal of Ophthalmology · doi:10.1155/2015/821918 · Cited by 10
“Subsequently, ARMS2/HTRA1 on chromosome 10q26 was discovered as the second major susceptibility gene for AMD [14, 35].”
BackgroundTsuchihashi, T., Mori, K., Horie, K., Okazaki, Y., Awata, T., Inoue, S., & Yoneya, S. (2014) · Clinical ophthalmology · doi:10.2147/opth.s71305 · Cited by 9
La dégénérescence maculaire liée à l’âge
Parier, V., & Soubrane, G. (2007) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2007.08.021 · Cited by 15
Complement Factor H: Using Atomic Resolution Structure to Illuminate Disease Mechanisms
Barlow, P. N., Hageman, G. S., & Lea, S. M. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_10 · Cited by 13
“2007) – as well as a significant association of three tightly linked genes (PLEKHA1, LOC387715 and PRSS11/HTRA1) on human chromosome 10q26 (Jakobsdottir et al. 2005; Rivera et al. 2005; Weeks et al. 2004).”
BackgroundHo, L., van Leeuwen, R., de Jong, P. T. V. M., Vingerling, J. R., & Klaver, C. C. W. (2012) · Springer eBooks · doi:10.1007/978-3-642-22107-1_1 · Cited by 10
Association of HTRA1 rs11200638 with age-related macular degeneration (AMD) in Brazilian patients
Lana, T. P., Costa, S. M. D. S., Ananina, G., Hirata, F. E., Rim, P. H. H., Medina, F. M., de Vasconcellos, J. P. C., & de Melo, M. B. (2017) · Ophthalmic Genetics · doi:10.1080/13816810.2017.1354382 · Cited by 9
Kan, M., Liu, F., Weng, X., Ye, J., Wang, T., Xu, M., He, L., & Liu, Y. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-73 · Cited by 9
“AMD might share common genetic risk factors [6-10].”
BackgroundGenetic and Epigenetic Regulation in Age-Related Macular Degeneration
Wei, L., Chen, P., Lee, J. H., & Nussenblatt, R. B. (2013) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0b013e31829e2793 · Cited by 8
Losonczy, G., Vajas, A., Takács, L., Dzsudzsák, E., Fekete, Á., Márhoffer, É., Kardos, L., Ajzner, É., Hurtado, B., de Frutos, P. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050181 · Cited by 8
“Ala69Ser (rs10490924) polymorphism in LOC387715 coding a protein of unknown function [19,20] or a promoter SNP of the HTRA serine peptidase 1 (HTRA1) gene (rs11200638) [21,22,23,24].”
BackgroundTorrini, M., Marchese, C. A., Vanzetti, M., Marini, V., Origone, P., Garrè, C., & Mareni, C. (2007) · Genetic Testing · doi:10.1089/gte.2007.0021 · Cited by 9
“Recent Recent findings suggest that PLEKHA1 / LOC387715 genes on chromosome 10 (Jakobsdottir et al ., 2005) and BF / C2 genes on chromosome 6 (Gold et al ., 2006) are also related to AMD.”
Detection of susceptibility genes as modifiers due to subgroup differences in complex disease
Bergen, S. E., Maher, B. S., Fanous, A. H., & Kendler, K. S. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.39 · Cited by 8
Genetics of Age-Related Macular Degeneration
Kasuga, D. T., Chen, Y., & Zhang, K. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0125-4_1 · Cited by 9
Larsen, P. P., Delyfer, M., Schweitzer, C., Korobelnik, J., & Delcourt, C. (2025) · Ophthalmology · doi:10.1016/j.ophtha.2025.01.002 · Cited by 9
Targeted Gene Candidates for Treatment and Early Diagnosis of Age‐Related Macular Degeneration
Çinici, E., Çağlar, Ö., Arslan, M. E., Dilekmen, N., Utlu, B., Mardinoğlu, A., & Türkez, H. (2021) · BioMed Research International · doi:10.1155/2021/6620900 · Cited by 10
“ABCA1 [9], ARMS2 [10], APOE [11, 12], CFH [13], CX3CR1 [14], CCR5 [15], ELOVL2 [16], HTRA1 [17], KCTD10 [18], TIMP3 [19], and VEGFA [20] are just a few of these genes reported being related to AMD.”
BackgroundPrioritization of Retinal Disease Genes: An Integrative Approach
Wagner, A. H., Taylor, K. R., DeLuca, A. P., Casavant, T. L., Mullins, R. F., Stone, E. M., Scheetz, T. E., & Braun, T. A. (2013) · Human Mutation · doi:10.1002/humu.22317 · Cited by 10
“…with multiple genes [Badano et al., 2003; Chiang et al., 2004; 2006; Mykytyn et al., 2001; 2002; Nishimura et al., 2001; 2005], and presumably complex disorders caused by numerous genetic and risk factors [Hageman et al., 2005; Haines et al., 2005; Jakobsdottir et al., 2005; Klein et al., 2005].”
BackgroundHao, S., Bai, J., Liu, H., Wang, L., Liu, T., Lin, C., Luo, X., Gao, J., Zhao, J., Li, H., et al. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.09.001 · Cited by 7
“Several genetic loci have been associated with AMD, including two major loci in the complement factor H ( CFH ) gene on 1q32 and the ARMS2/HTRA1 locus on the 10q26 gene cluster [30,31].”
BackgroundUse of saffron as a functional food and saffron nutraceuticals
Monte, C. D., & Cesa, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821219-6.00007-5 · Cited by 9
The role of molecular genetic factors in age-related macular degeneration
de Almeida, L. N. F., Melilo-Carolino, R., Sperandio, D. C., Nehemy, M. B., & Marco, L. D. (2009) · Arquivos Brasileiros de Oftalmologia · doi:10.1590/s0004-27492009000400027 · Cited by 10
“4) for the heterozygous and homozygous states, respectively((15)).”
BackgroundInfluentialDry age-related macular degeneration and age-related macular degeneration pathogenesis
Zarbin, M. A., & Sunness, J. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-2983-7.00068-1 · Cited by 8
Retinal function and CFH-ARMS2 polymorphisms analysis: a pilot study in Italian AMD patients
Capoluongo, E., Concolino, P., Piccardi, M., Marangoni, D., Mello, E., Minnella, A. M., Savastano, M. C., Fadda, A., Zuppi, C., Bisti, S., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.008 · Cited by 7
Conley, Y. P., Jakobsdóttir, J., Mah, T. S., Weeks, D. E., Klein, R. B., Kuller, L. H., Ferrell, R. E., & Gorin, M. B. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.02.012 · Cited by 6
“Three studies support the PLEKHA1/LOC387715 locus on chromosome 10q26 (12,16,17).”
BackgroundMethodResultInfluentialSelf-citationChen, J., Yang, Y., Zheng, Y., Qiu, M., Xie, M., Lin, W., Zhang, M., Pang, C. P., & Chen, H. (2013) · PubMed Central · Cited by 6
Jahanfar, F., & Hamishehkar, H. (2018) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.12.023 · Cited by 6
Age-related macular degeneration with discordant late stage phenotypes in monozygotic twins
Keilhauer, C. N., Fritsche, L. G., & Weber, B. H. F. (2011) · Ophthalmic Genetics · doi:10.3109/13816810.2011.592177 · Cited by 6
LeCouter, J. E., & Scheer, J. M. (2014) · Expert Review of Ophthalmology · doi:10.1586/17469899.2014.918846 · Cited by 5
“ARMS2 and HTRA1 locus at 10q26 associated with development of intermediate and advance AMD [19,20].”
BackgroundAblation of Htra1 leads to sub-RPE deposits and photoreceptor abnormalities
Biswas, P., Woodard, D. R., Hollingsworth, T., Khan, N. W., Lazaro, D., Berry, A. M., Dagar, M., Pan, Y., Garland, D. L., Shaw, P. X., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.178827 · Cited by 5
“Because of its role in the retinal ECM, recent studies have suggested a potential role for HTRA1 in the development of BM abnormalities and RPE pathology (12, 13, 15, 21, 23–25).”
InfluentialXia, N., Zhao, Q., Xu, J., & Cheng, Z. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010276304240103084841 · Cited by 5
Importance of genetic polymorphisms in the response to age-related macular degeneration treatment
Veloso, C. E. D. R., de Almeida, L. N. F., Marco, L. A. D., Vianna, R. N. G., & Nehemy, M. B. (2012) · Revista Brasileira de Oftalmologia · doi:10.1590/s0034-72802012000300011 · Cited by 5
“also found to confer an increased risk for development of AMD.(33-50) Some papers suggested that the vascular”
BackgroundInfluentialAge-related macular degeneration (AMD): Current concepts in pathogenesis and prospects for treatment
Shin, O. R., & Kim, Y. H. (2013) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-012-0374-0 · Cited by 7
Jiang, J., Wu, X., Zhou, P., Yu, W. Z., Huang, L., & Li, X. X. (2012) · Genetics and Molecular Research · doi:10.4238/2012.december.17.1 · Cited by 5
“In addition, chromosome 10q26 has been reported to harbor three important AMD susceptible genes, including Pleckstrin homology domain-containing protein family A member 1, age-related maculopathy susceptibility 2 (LOC387715/ARMS2), and high-temperature requirement factor A 1 (HTRA1/PRSS11) (Jakobsdottir et al., 2005;…”
BackgroundOczos, J., Grimm, C., Barthelmes, D., Sutter, F., Menghini, M., Kloeckener‐Gruissem, B., & Berger, W. (2012) · AGE · doi:10.1007/s11357-012-9467-x · Cited by 8
Association of Htra1 gene polymorphisms with the risk of developing AMD in Iranian population.
Askari, M., Nikpoor, A. R., Gorjipour, F., Mazidi, M., Sanati, M. H., Aryan, H., Irani, A., Falavarjani, K. G., Nazari, H. K., & Mousavizadeh, K. (2015) · Europe PMC (PubMed Central) · Cited by 7
Mechanisms of Oxidative Stress in Retinal Injury
Brantley, M. A., & Sternberg, P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00022-9 · Cited by 9
Overexpression of HTRA1 increases the proliferation and migration of retinal pigment epithelium
Zhou, J., Chen, F., Yan, A.-M., & Xia, X. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/135939 · Cited by 6
“15 Specific HTRA1 alleles are related to neovascular lesion extent.”
Fenner, B. J., Li, H., Gan, A. T. L., Song, Y. S., Tham, Y. C., Jonas, J. B., Wang, Y. X., Cheng, C., Wong, T. Y., Teo, K. Y. C., et al. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.2.10 · Cited by 5
Cruz-González, F., Lorenzo-Pérez, R., Cañete-Campos, C., Hernández-Galilea, E., & González‐Sarmiento, R. (2012) · Archivos de la Sociedad Española de Oftalmología · doi:10.1016/j.oftal.2012.04.019 · Cited by 5
Honda, S., Misawa, N., Sato, Y., Oikawa, D., & Tokunaga, F. (2024) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-024-06442-9 · Cited by 4
Genetics in Age-Related Macular Degeneration: Current Research and Implications for Future Treatment
Broadhead, G., Chang, A., & McCluskey, P. (2012) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0b013e31826e1d4a · Cited by 4
Complement Mediators in Development to Treat Age-Related Macular Degeneration
Nebbioso, M., Franzone, F., Lambìase, A., Taurone, S., Artico, M., Gharbiya, M., Greco, A., & Polimeni, A. (2022) · Drugs & Aging · doi:10.1007/s40266-021-00914-x · Cited by 5
Wong, C. W., Liao, J., Cheung, C. M. G., Khor, C. C., Vithana, E. N., Wang, J. J., Mitchell, P., Aung, T., Wong, T. Y., & Cheng, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119570 · Cited by 4
“Subsequently, ARMS2/HTRA1 on chromosome 10q26 was also found to be associated with risk of AMD [12,13].”
BackgroundThe Chromosome 10q26 Susceptibility Locus in Age-Related Macular Degeneration
Stanton, C. M., Chalmers, K. J., & Wright, A. F. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0631-0_47 · Cited by 4
Cruz-González, F., Lorenzo-Pérez, R., Cañete-Campos, C., Hernández-Galilea, E., & González‐Sarmiento, R. (2013) · Archivos de la Sociedad Española de Oftalmología (English Edition) · doi:10.1016/j.oftale.2013.02.001 · Cited by 3
Huang, Y., Liao, W., Lin, H., Huang, Y.-T., Chang, Y., Liu, T., Chen, Y.-C., Weng, A. L., & Tsai, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063230 · Cited by 4
GWAS SVatalog: a visualization tool to aid fine-mapping of GWAS loci with structural variations
Chirmade, S., Wang, Z., Mastromatteo, S., Sanders, E., Thiruvahindrapuram, B., Nalpathamkalam, T., Pellecchia, G., Fan, L., Keenan, K., Patel, R. V., et al. (2025) · Heredity · doi:10.1038/s41437-025-00809-2 · Cited by 5
“For example, in a GWAS investigating age-related macular degeneration (AMD), a study fi rst identi fi ed rs10490924 as associated with disease risk (Rivera et al., 2005) and this was replicated in multiple independent studies (Jakobs-dottir et al., 2005; Fritsche et al., 2008; Micklisch et al., 2017).”
Cruz-González, F., Cabrillo-Estevez, L., Campos, C. C., Sanchez, A., Marcos, L. J., & González‐Sarmiento, R. (2016) · Archivos de la Sociedad Española de Oftalmología (English Edition) · doi:10.1016/j.oftale.2015.12.015 · Cited by 3
Murphy, C. E., Johnson, A. P., Koenekoop, R. K., Seiple, W., & Overbury, O. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.586691 · Cited by 3
Role of ARMS2/HTRA1 risk alleles in the pathogenesis of neovascular age-related macular degeneration
Pan, Y., & Iwata, T. (2024) · Taiwan Journal of Ophthalmology · doi:10.4103/tjo.tjo-d-23-00152 · Cited by 4
Advanced nanomedicines for the treatment of age-related macular degeneration
Kwon, Y., & Han, Z. (2024) · Nanoscale · doi:10.1039/d4nr01917b · Cited by 3
Epidemiology and Risk Factors for Age-Related Macular Degeneration
Seddon, J. M., & Sobrin, L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00063-1 · Cited by 6
Williams, B. L., Zouache, M. A., Seager, N. A., Pappas, C. M., Liu, J., Anstadt, R. A., Hubbard, W. C., Thomas, J., Hageman, J. L., Mohler, J., et al. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.4.34 · Cited by 3
Chow, S.-P., Dean, M. M., Depla, J. A., Daniell, M. D., & Eisen, D. P. (2011) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02572.x · Cited by 3
Génétique de la dégénérescence maculaire liée à l’âge
Souied, E. H., Leveziel, N., Kaplan, J., & Soubrane, G. (2007) · Journal Français d Ophtalmologie · doi:10.1016/s0181-5512(07)89680-x · Cited by 3
“Jakobsdottir et al., 2005 [82], ont procédé à une analyse systématique des SNPs de la région d’intérêt en 10q26, identifiée par Weeks et al. [28].”
Popp, N. A., Agrón, E., Hageman, G. S., Tuo, J., Chew, E. Y., & Chan, C. (2016) · Current Eye Research · doi:10.1080/02713683.2016.1196708 · Cited by 4
“viously associated with AMD: rs1061170, rs1410996, and rs3766404 in CFH, rs10490924 in ARMS2, and rs2230199 in C3.(16,18,25,28,36,37) All SNPs except for rs1061170 were genotyped using the MassARRAY MALDI-TOF mass spectro-”
MethodHuang, Q., & Xiang, Y. (2018) · Medical Science Monitor · doi:10.12659/msm.906298 · Cited by 3
Review of Emerging Treatments for Age-Related Macular Degeneration
Zarbin, M. A., & Rosenfeld, P. J. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-606-7_1 · Cited by 3
Dégénérescence maculaire liée à l’âge et génétique : données actuelles
Fajnkuchen, F., & Cohen, S. Y. (2008) · Journal Français d Ophtalmologie · doi:10.1016/s0181-5512(08)75469-x · Cited by 5
Genetics of Age-Related Macular Degeneration
Zavala, R. A., Hicks, P. M., Lillvis, J. H., Zhang, C., Farkas, M. H., Owen, L. A., & DeAngelis, M. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_110 · Cited by 3
The Role of Inflammation in Age-Related Macular Degeneration
Harris, J. M., & Wu, D. M. (2025) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000578 · Cited by 2
Revisiting retinal and macular degeneration in the genomics era
Swaroop, A., & Roska, B. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00960-4 · Cited by 3
“Immediately thereafter, a second AMD locus was ascertained at chromosome 10q26 157–159 , and strong associations were uncovered for independent non-coding variants at the CFH locus 160,161 .”
A Novel Web-Based Clinical Research Tool for a Nationwide Research Study
Ortube, M. C. (2012) · Journal of Clinical Research & Bioethics · doi:10.4172/2155-9627.1000145 · Cited by 2
“In that time frame, clinical information has been gathered on more than 700 families of individuals with ARM [11-22].”
BackgroundΓιαννόπουλος, Κ., Gazouli, M., CHATZISTEFANOU, K. I., Gouliopoulos, N., Lavaris, A., Bakouli, A., & Moschos, M. M. (2023) · European Journal of Ophthalmology · doi:10.1177/11206721231155043 · Cited by 2
“Rs10490924 SNP of ARMS2 gene results in an alanine to serine substitution at codon 69 (A69S).(25,26) Kortvely et al.”
Background
Metadata
- Authors
- Jakobsdottir, J., Conley, Y. P., Weeks, D. E., Mah, T. S., Ferrell, R. E., & Gorin, M. B.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Gorin, Michael B.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 77
- Issue
- 3
- Pages
- 389-407
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1226205
- OpenAlex
- W4238550599
- Cited by
- 470
- References
- 50
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 11 · 2023: 6 · 2022: 12 · 2021: 21 · 2020: 13 · 2019: 1 · 2018: 12 · 2017: 12 · 2016: 12 · 2015: 19 · 2014: 27 · 2013: 42 · 2012: 33
- FWCI
- 33.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2878 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (n01hg065403-000)
- National Human Genome Research Institute (N01 HG065403)
- National Eye Institute (R01EY009859)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- age-related maculopathy, chromosome 10q26, LOC387715, genetic susceptibility, non-synonymous SNPs, genetic linkage, population attributable risk
- MeSH terms
- Chromosome Mapping, Chromosomes, Human, Pair 10, Gene Frequency, Humans, Genetic Linkage, Macular Degeneration, Membrane Proteins, Pedigree, United States, Cohort Studies, Linkage Disequilibrium, Odds Ratio, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, White People, Intracellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.